Korea FDA Allows Emergency Use Of Intravenous Peramivir for Seriously Ill A/H1N1 Patients

SEOUL - For the first time in its fight against A/H1N1, the Korea Food & Drug Administration allowed the use of injectable antiviral peramivir in a seriously-ill patient even though the product is not yet approved in South Korea